Alector, Inc. Common Stock

ALECNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
1.47 USD
↘ 0.03 (2.00%)AT CLOSE (11:59 AM EDT)
1.34
↘ 0.13 (8.84%)
POST MARKET (AS OF 06:16 PM EDT)
Post Market
AS OF 06:16 PM EDT
1.34
↘ 0.13 (8.84%)
🟢Market: OPEN

Shares of Alector, Inc. Common Stock (ALEC) are trading at $1.50. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jul 16, 2026.

Open?$1.40
High?$1.50
Low?$1.39
Prev. Close?$1.50
Volume?713.5K
Avg. Volume?855.0K
VWAP?$1.44
Rel. Volume?0.83x
Bid / Ask
Bid?$0.99 × 100
Ask?$1.68 × 100
Spread?$0.69
Midpoint?$1.33
Valuation & Ratios
Market Cap?166.5M
Shares Out?111.0M
Float?87.9M
Float %?79.1%
P/E Ratio?N/A
P/B Ratio?16.04
EPS?-$1.13
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related Therapeutics
Employees
103
Market Cap
166.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.alector.com
Listed
2019-02-07
Address
131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-231-5660
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
44
Piotroski F-Score?2/9Weak
Altman Z-Score?-6.30Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.51%Elevated
Short Interest?5.7M
Days to Cover?4.4
Free Float87.9M
Avg Daily Volume1.3M
Settlement Date2026-06-30
Financial Health
Current Ratio?5.25Strong
Quick Ratio?5.25Strong
Cash Ratio?1.88Strong
Debt/Equity?0.94Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
10
16.04HIGH▾
P/S?
Peers
100
S&P
10
9.04HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.8CHEAP▾
EV/Sales?
Peers
100
S&P
33
5.39FAIR▾
Returns & Efficiency
ROE?
S&P
3
-1,210.3%WEAK▾
ROA?
S&P
3
-52.4%WEAK▾
Cash Flow & Enterprise
FCF?$-173200000
Enterprise Value?$99.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist